InsidersTradesSigma
Track the 华特达因 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华特达因 has recorded 4 insider filings. Market capitalisation: €5.9bn. The latest transaction was disclosed on 24 April 2026 (Purchase). Among the most active insiders: 范智胜. The full history is free.
4
Insider Decl.
n/a
Thresholds
€250,502
4 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 102 of 28,803 companies
90.6
score / 100
Value90
Quality92
FCF yld20%
Earn yld8.8%
EV/EBITDA4.8x
ROE20%
Gross mgn85%
Net mgn24%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2026
About 华特达因
华特达因 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical and healthcare products.